We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTX icon
4801
Entera Bio
ENTX
$147M
$50K ﹤0.01%
17,597
PPBT
4802
Purple Biotech
PPBT
$1.31M
$50K ﹤0.01%
63
TTNP
4803
DELISTED
Titan Pharmaceuticals
TTNP
$50K ﹤0.01%
2,653
HEXO
4804
DELISTED
HEXO Corp. Common Shares
HEXO
$50K ﹤0.01%
5,766
CRXT
4805
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$50K ﹤0.01%
+33,915
New +$43.1K
ALZN icon
4806
Alzamend Neuro
ALZN
$6.28M
$49K ﹤0.01%
30
+8
+36% +$15K
NMAD
4807
Nomad Power Solutions
NMAD
$81.9M
$49K ﹤0.01%
4,097
+31
+0.8% +$502
SBFM
4808
Sunshine Biopharma
SBFM
$2.78M
$49K ﹤0.01%
+1
New +$48.7K
GMVD
4809
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$49K ﹤0.01%
1,113
-1,013
-48% -$99.1K
CLLS
4810
Cellectis
CLLS
$277M
$48K ﹤0.01%
10,776
FWDI
4811
Forward Industries Inc
FWDI
$297M
$48K ﹤0.01%
2,814
IFRX icon
4812
InflaRx
IFRX
$250M
$48K ﹤0.01%
26,327
+7,336
+39% +$22.9K
LVTX
4813
DELISTED
LAVA Therapeutics
LVTX
$48K ﹤0.01%
11,124
+1,038
+10% +$5.27K
MAMA icon
4814
Mama's Creations
MAMA
$857M
$48K ﹤0.01%
28,985
+16,180
+126% +$28.9K
SSY
4815
DELISTED
SunLink Health Systems
SSY
$48K ﹤0.01%
32,987
TAIT
4816
DELISTED
Taitron Components
TAIT
$48K ﹤0.01%
12,619
VIVO
4817
VivoPower PLC
VIVO
$110M
$48K ﹤0.01%
+2,759
New +$63.6K
ANY icon
4818
Sphere 3D
ANY
$18.5M
$47K ﹤0.01%
324
CHR icon
4819
Cheer Holding
CHR
$3.47M
$47K ﹤0.01%
30
XMAX
4820
XMAX Inc
XMAX
$548M
$46K ﹤0.01%
6,283
CBAT icon
4821
CBAK Energy Technology Ltd
CBAT
$44.3M
$45K ﹤0.01%
35,345
NSPR icon
4822
InspireMD
NSPR
$30.4M
$45K ﹤0.01%
14,051
STRR
4823
DELISTED
Star Equity Holdings
STRR
$45K ﹤0.01%
8,014
CNTG
4824
DELISTED
Centogene N.V. Common Shares
CNTG
$45K ﹤0.01%
11,156
-1
-0% -$4
DTSS icon
4825
Datasea Intelligent Technology Ltd
DTSS
$7.33M
$44K ﹤0.01%
1,076
+171
+19% +$4.9K

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.